Your browser doesn't support javascript.
loading
miR-21 inhibition reverses doxorubicin-resistance and inhibits PC3 human prostate cancer cells proliferation.
Zhao, Weichong; Ning, Lei; Wang, Lihui; Ouyang, Tao; Qi, Lei; Yang, Ruihong; Wu, Yanlin.
Afiliação
  • Zhao W; Department of Oncology, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China.
  • Ning L; Department of Clinical Laboratory, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China.
  • Wang L; Health Physical Examination Department, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China.
  • Ouyang T; Department of Urology Surgery, Pingyin County Hospital of Traditional Chinese Medicine, Jinan, Shandong Province, China.
  • Qi L; Intensive Care Unit, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China.
  • Yang R; Intensive Care Unit, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China.
  • Wu Y; Department of Urology Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China.
Andrologia ; 53(5): e14016, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33598946
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / MicroRNAs Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / MicroRNAs Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China